CRISPR Therapeutics announces chief financial officer transition
CRSP•CRISPR Therapeutics said Raju Prasad stepped down as CFO and appointed A.J. Silver as CFO, effective today.
1. CFO transition
CRISPR Therapeutics said Raju Prasad stepped down as chief financial officer and appointed A.J. Silver to the role, effective today.
Related News
Thomson Reuters continues to expect Global Print deal to add 60-70 basis points to annual organic revenue growth
TRI•
Fortrea completes acquisition of the Early Phase Services division from Worldwide Clinical Trials
FTRE•
